JK
James N. Kochenderfer is a physician-scientist at the National Cancer Institute whose research focuses on chimeric antigen receptor (CAR) T-cell therapy for hematologic malignancies. His work has contributed to the development of anti-CD19 CAR T-cell treatments for lymphoma and leukemia, and he has studied CAR T cells for multiple myeloma.
- Field
- Medicine · Oncology
- Clarivate categories
- Clinical Medicine
- Affiliation
- NIH National Cancer Institute (NCI), United States